Active Ingredient(s): Besifloxacin
FDA Approved: * May 28, 2009
Pharm Company: * BAUSCH AND LOMB
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Besivance Overview

Besifloxacin (INN/USAN) is a fourth-generation fluoroquinolone antibiotic. The marketed compound is besifloxacin hydrochloride. It was developed by SSP Co. Ltd., Japan, and designated SS734. SSP licensed U.S. and European rights to SS734 for ophthalmic use to InSite Vision Incorporated (OTC Pink: INSV) in 2000. InSite Vision developed an eye drop formulation (ISV-403) and conducted preliminary clinical trials before selling the product and all rights to Bausch & Lomb in 2003.[1&am...

Read more Besivance Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Besivance Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Suspension: 0.6%
  • Suspension/drops: 0.6%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Besivance: (3 results)

Sorted by National Drug Code
  • 24208-446 Besivance 6 mg/ml Ophthalmic Suspension by Bausch & Lomb Incorporated
  • 50090-1241 Besivance 6 mg/ml Ophthalmic Suspension by A-s Medication Solutions
  • 54868-6282 Besivance 6 mg/ml Ophthalmic Suspension by Physicians Total Care, Inc.

Other drugs which contain Besifloxacin or a similar ingredient: (1 result)